Corline Biomedical AB Market Cap

Corline Biomedical AB has a market cap or net worth of 400.85 million as of March 9, 2026. Its market cap has increased by 52.26% in one year.

Market Cap

400.85M

Enterprise Value

380.30M

Revenue

8.59M

Ranking

n/a

PE Ratio

n/a

Stock Price

15.65

Market Cap Chart

Since June 3, 2015, Corline Biomedical AB's market cap has increased from 97.97M to 400.85M, an increase of 309.18%. That is a compound annual growth rate of 13.98%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	407.26M	15.55%
Dec 30, 2025	352.45M	86.79%
Dec 30, 2024	188.69M	-41.07%
Dec 29, 2023	320.21M	61.61%
Dec 30, 2022	198.15M	-36.85%
Dec 30, 2021	313.77M	25.86%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Oncopeptides AB	431.42M
Ascelia Pharma AB	366.65M
Elicera Therapeutics AB	315.48M
Bio-Works Technologies AB	315.18M
FluoGuide	542.80M
Lipum AB	304.40M
Mendus AB	258.28M
Infant Bacterial Therapeutics AB	674.92M

Market Cap Rankings